Difficulty: Medium
Average Score: 91%
Practice
Following is an excitatory amino acid receptor antagonist?
Correct answer
A
Rationale
In this question about excitatory amino acid receptor antagonists, the correct answer is A) Phencyclidine. Phencyclidine, commonly known as PCP, acts as an antagonist at the N-methyl-D-aspartate (NMDA) receptor, which is a type of excitatory amino acid receptor. PCP's mechanism of action involves blocking the activity of the NMDA receptor, thereby inhibiting the effects of glutamate, an excitatory neurotransmitter.
Option B) Quisqualate is an agonist, not an antagonist, of the ionotropic glutamate receptors. Quisqualate binds and activates these receptors, leading to excitatory effects.
Option C) Homocysteate is not a pharmacological agent but rather a naturally occurring amino acid in the body. It is not known to act as an excitatory amino acid receptor antagonist.
Option D) Kainate is another agonist of ionotropic glutamate receptors, similar to quisqualate. It binds to these receptors and induces excitatory responses, rather than inhibiting them like an antagonist would.
Understanding the distinctions between agonists and antagonists of excitatory amino acid receptors is crucial in pharmacology. Knowing how different drugs interact with these receptors can help in developing treatments for various neurological conditions, such as epilepsy or neurodegenerative disorders. By grasping these concepts, pharmacologists and healthcare professionals can make informed decisions about drug therapies and their potential effects on the central nervous system.
Option B) Quisqualate is an agonist, not an antagonist, of the ionotropic glutamate receptors. Quisqualate binds and activates these receptors, leading to excitatory effects.
Option C) Homocysteate is not a pharmacological agent but rather a naturally occurring amino acid in the body. It is not known to act as an excitatory amino acid receptor antagonist.
Option D) Kainate is another agonist of ionotropic glutamate receptors, similar to quisqualate. It binds to these receptors and induces excitatory responses, rather than inhibiting them like an antagonist would.
Understanding the distinctions between agonists and antagonists of excitatory amino acid receptors is crucial in pharmacology. Knowing how different drugs interact with these receptors can help in developing treatments for various neurological conditions, such as epilepsy or neurodegenerative disorders. By grasping these concepts, pharmacologists and healthcare professionals can make informed decisions about drug therapies and their potential effects on the central nervous system.